Infliximab treatment of severe ankylosing spondylitis: one-year followup.
Brandt
J
J
Haibel
H
H
Sieper
J
J
Reddig
J
J
Braun
J
J
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D000069285:Infliximab; D013167:Spondylitis, Ankylosing / Q000628:therapy*
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab